HL
Harding Loevner’s Genmab GMAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.4M | Buy |
2,923,439
+42,613
| +1% | +$881K | 0.41% | 55 |
|
|
2025
Q1 | $56.4M | Buy |
2,880,826
+637,434
| +28% | +$12.5M | 0.43% | 52 |
|
|
2024
Q4 | $46.8M | Sell |
2,243,392
-823,550
| -27% | -$17.2M | 0.32% | 52 |
|
|
2024
Q3 | $74.7M | Buy |
3,066,942
+299,137
| +11% | +$7.29M | 0.43% | 51 |
|
|
2024
Q2 | $69.6M | Sell |
2,767,805
-526,923
| -16% | -$13.3M | 0.38% | 58 |
|
|
2024
Q1 | $98.5M | Buy |
3,294,728
+4,833
| +0.1% | +$145K | 0.61% | 49 |
|
|
2023
Q4 | $97.6M | Buy |
3,289,895
+85,665
| +3% | +$2.54M | 0.55% | 56 |
|
|
2023
Q3 | $113M | Buy |
3,204,230
+3,036,109
| +1,806% | +$107M | 0.75% | 49 |
|
|
2023
Q2 | $6.39M | Sell |
168,121
-2,029
| -1% | -$77.1K | 0.04% | 62 |
|
|
2023
Q1 | $6.43M | Buy |
170,150
+47,238
| +38% | +$1.79M | 0.04% | 68 |
|
|
2022
Q4 | $5.2M | Sell |
122,912
-6,308
| -5% | -$267K | 0.03% | 74 |
|
|
2022
Q3 | $4.15M | Sell |
129,220
-1,061
| -0.8% | -$34.1K | 0.03% | 73 |
|
|
2022
Q2 | $4.24M | Sell |
130,281
-6,667
| -5% | -$217K | 0.03% | 74 |
|
|
2022
Q1 | $4.96M | Buy |
136,948
+1,827
| +1% | +$66.1K | 0.03% | 77 |
|
|
2021
Q4 | $5.35M | Buy |
135,121
+3,098
| +2% | +$123K | 0.02% | 79 |
|
|
2021
Q3 | $5.77M | Sell |
132,023
-267
| -0.2% | -$11.7K | 0.02% | 77 |
|
|
2021
Q2 | $5.4M | Buy |
132,290
+13,012
| +11% | +$531K | 0.02% | 76 |
|
|
2021
Q1 | $3.92M | Sell |
119,278
-5,050
| -4% | -$166K | 0.02% | 80 |
|
|
2020
Q4 | $5.06M | Buy |
+124,328
| New | +$5.06M | 0.02% | 71 |
|